182 related articles for article (PubMed ID: 30117014)
1. Are there any metastases to the chest in non-muscle-invasive bladder cancer patients on follow-up computed tomography?
Juri H; Koyama M; Azuma H; Narumi Y
Int Urol Nephrol; 2018 Oct; 50(10):1771-1778. PubMed ID: 30117014
[TBL] [Abstract][Full Text] [Related]
2. Recurrence patterns of bladder transitional cell carcinoma after radical cystectomy.
Kim B; Choi HJ; Kim MH; Cho KS
Acta Radiol; 2012 Oct; 53(8):943-9. PubMed ID: 22893727
[TBL] [Abstract][Full Text] [Related]
3. Role of whole-body staging computed tomographic scans for detecting distant metastases in patients with bladder cancer.
Rajesh A; Sokhi H; Fung R; Mulcahy KA; Bankart MJ
J Comput Assist Tomogr; 2011; 35(3):402-5. PubMed ID: 21586938
[TBL] [Abstract][Full Text] [Related]
4. Upper tract imaging surveillance is not effective in diagnosing upper tract recurrence in patients followed for nonmuscle invasive bladder cancer.
Sternberg IA; Keren Paz GE; Chen LY; Herr HW; Donat SM; Bochner BH; Dalbagni G
J Urol; 2013 Oct; 190(4):1187-91. PubMed ID: 23680310
[TBL] [Abstract][Full Text] [Related]
5. Local recurrence and progression of non-muscle-invasive bladder cancer in Sweden: a population-based follow-up study.
Liedberg F; Hagberg O; Holmäng S; Hosseini Aliabad A; Jancke G; Ljungberg B; Malmström PU; Åberg H; Jahnson S
Scand J Urol; 2015; 49(4):290-5. PubMed ID: 25624049
[TBL] [Abstract][Full Text] [Related]
6. [Application of chest CT scan in gestational trophoblastic neoplasia with lung metastasis].
Cheng Y; Ma FH; Wang XR; Le XN; Zhang GF; Lu X
Zhonghua Fu Chan Ke Za Zhi; 2018 Jun; 53(6):384-389. PubMed ID: 29961280
[No Abstract] [Full Text] [Related]
7. Prognostic significance in substaging ofT1 urinary bladder urothelial carcinoma on transurethral resection.
Chang WC; Chang YH; Pan CC
Am J Surg Pathol; 2012 Mar; 36(3):454-61. PubMed ID: 22261706
[TBL] [Abstract][Full Text] [Related]
8. Preoperative lymph-node staging of invasive urothelial bladder cancer with 18F-fluorodeoxyglucose positron emission tomography/computed axial tomography and magnetic resonance imaging: correlation with histopathology.
Jensen TK; Holt P; Gerke O; Riehmann M; Svolgaard B; Marcussen N; Bouchelouche K
Scand J Urol Nephrol; 2011 Mar; 45(2):122-8. PubMed ID: 21231796
[TBL] [Abstract][Full Text] [Related]
9. Routine Staging Using Chest Computed Tomography in Workup of Treatment-Naïve Hepatocellular Carcinoma Prior to Locoregional Therapy: Is There a Need?
Leong PW; Pua U; Lim KS
Ann Acad Med Singap; 2017 Jul; 46(7):282-286. PubMed ID: 28821892
[TBL] [Abstract][Full Text] [Related]
10. Pattern of metastases in relation to characteristics of primary tumor and treatment in patients with disseminated urothelial carcinoma.
Sengeløv L; Kamby C; von der Maase H
J Urol; 1996 Jan; 155(1):111-4. PubMed ID: 7490804
[TBL] [Abstract][Full Text] [Related]
11. Follow-up after radical cystectomy based on patterns of tumour recurrence and its risk factors.
Huguet J
Actas Urol Esp; 2013 Jun; 37(6):376-82. PubMed ID: 23611464
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma.
Milojevic B; Djokic M; Sipetic-Grujicic S; Grozdic Milojevic I; Vuksanovic A; Nikic P; Vukovic I; Djordjevic D; Bumbasirevic U; Tulic C
Urol Oncol; 2013 Nov; 31(8):1615-20. PubMed ID: 22521771
[TBL] [Abstract][Full Text] [Related]
13. Lymph node metastases in non-muscle invasive bladder cancer are correlated with the number of transurethral resections and tumour upstaging at radical cystectomy.
Wiesner C; Pfitzenmaier J; Faldum A; Gillitzer R; Melchior SW; Thüroff JW
BJU Int; 2005 Feb; 95(3):301-5. PubMed ID: 15679782
[TBL] [Abstract][Full Text] [Related]
14. Lymphovascular invasion in transurethral resection specimens as predictor of progression and metastasis in patients with newly diagnosed T1 bladder urothelial cancer.
Cho KS; Seo HK; Joung JY; Park WS; Ro JY; Han KS; Chung J; Lee KH
J Urol; 2009 Dec; 182(6):2625-30. PubMed ID: 19836779
[TBL] [Abstract][Full Text] [Related]
15. RUNX3 methylation as a predictor for disease progression in patients with non-muscle-invasive bladder cancer.
Yan C; Kim YW; Ha YS; Kim IY; Kim YJ; Yun SJ; Moon SK; Bae SC; Kim WJ
J Surg Oncol; 2012 Mar; 105(4):425-30. PubMed ID: 22311819
[TBL] [Abstract][Full Text] [Related]
16. Should preoperative chest CT be recommended to all colon cancer patients?
Kim HY; Lee SJ; Lee G; Song L; Kim SA; Kim JY; Chang DK; Rhee PL; Kim JJ; Rhee JC; Chun HK; Kim YH
Ann Surg; 2014 Feb; 259(2):323-8. PubMed ID: 23426347
[TBL] [Abstract][Full Text] [Related]
17. Multicenter evaluation of the role of UroVysion FISH assay in surveillance of patients with bladder cancer: does FISH positivity anticipate recurrence?
Seideman C; Canter D; Kim P; Cordon B; Weizer A; Oliva I; Rao J; Inman BA; Posch M; Herr H; Lotan Y
World J Urol; 2015 Sep; 33(9):1309-13. PubMed ID: 25420920
[TBL] [Abstract][Full Text] [Related]
18. Local recurrence after radical cystectomy for invasive bladder cancer: an analysis of predictive factors.
Honma I; Masumori N; Sato E; Takayanagi A; Takahashi A; Itoh N; Tamagawa M; Sato MA; Tsukamoto T
Urology; 2004 Oct; 64(4):744-8. PubMed ID: 15491713
[TBL] [Abstract][Full Text] [Related]
19. Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study.
Lamm DL; Blumenstein BA; Crissman JD; Montie JE; Gottesman JE; Lowe BA; Sarosdy MF; Bohl RD; Grossman HB; Beck TM; Leimert JT; Crawford ED
J Urol; 2000 Apr; 163(4):1124-9. PubMed ID: 10737480
[TBL] [Abstract][Full Text] [Related]
20. Analysis of factors predicting intravesical recurrence of superficial transitional cell carcinoma of the bladder without concomitant carcinoma in situ.
Sakai I; Miyake H; Harada K; Hara I; Inoue TA; Fujisawa M
Int J Urol; 2006 Nov; 13(11):1389-92. PubMed ID: 17083389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]